Axis Research & Technologies Appoints Dr. Mark G. Freeman as Chief Medical Advisor

Medical technology company expands strategic leadership team, medical device and surgical outreach abilities with expert clinical guidance

Axis Research & Technologies, a premier bioskills training and cadaver lab supporting medical device research and training, is proud to introduce Dr. Mark G. Freeman as the company’s Chief Medical Advisor. As a board-certified orthopedic surgeon and practicing physician with Erlanger Health System, Dr. Freeman brings a unique perspective, expert clinical guidance, and surgical expertise to the revolutionary medical education labs.

Dr. Freeman has built a strong reputation for excellence with his ability to manage complex conditions including primary and revision surgeries, fractures, and musculoskeletal infections. With a biomedical engineering degree in addition to his medical education, Dr. Freeman serves as a research abstract reviewer for the American Association of Hip and Knee Surgeons, has clinical and lab research interests, and collaborates with the biomedical device and technology industry.

Well-respected across the United States for its work in supporting research, development and medical education, Axis has tapped Dr. Freeman to provide clinical input and strategic advice for enhancing labs or events from the perspective of a practicing surgeon. Additionally, Axis  serves the didactic and cadaveric training needs of medical device companies. Dr. Freeman’s interest in supporting visiting surgeons are a natural outgrowth of his own commitment to remaining a lifelong learner and encouraging the same in others.

“Axis is very fortunate to be working with Dr. Freeman,” said Nick Moran, CEO of Axis. “His status in the community and the market, his credibility as a practicing physician and his understanding of the needs of our medical device and surgical clients give us an unparalleled view into providing a full-service experience for every company or team that enters one of our bioskills labs.”

Dr. Freeman also serves as a liaison between Axis and universities, healthcare systems, academic facilities and surgery centers that will benefit from the capabilities, technologies and global, HIPAA-compliant training platform offered at all elite Axis facilities. Axis’ labs and event spaces are flexible and welcoming, supporting a wide range of specialties and disciplines.

“As a surgeon who continues to take advantage of every opportunity to learn, I’m deeply invested in helping Axis continually evolve its facilities to meet the changing needs of clients,” said Dr. Freeman. “As Chief Medical Advisor for Axis, I am proud to assist healthcare clients by offering them insights into how they can best optimize their labs and training experiences at Axis facilities.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.